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Many important problems in cell biology emerge from the dense nonlinear interactions 
between functional modules. The importance of mathematical modeling and computer 
simulation in understanding cellular processes is now indisputable and widely 
appreciated, and genome-scale metabolic models have gained much popularity and utility 
in helping us to understand and test hypotheses about these complex networks. However, 
there are some caveat utilitor that come with the use and interpretation of different types 
of metabolic models that we aim to highlight here. We discuss and illustrate how the 
integration of thermodynamic and kinetic properties of the yeast metabolic networks in 
network analyses can help in understanding and utilizing this organism more successfully 
in the areas of metabolic engineering, synthetic biology, and disease treatment. 
 
INTRODUCTION  
Yeast has been used for the production of food, beverages and ingredients, fuels, 
chemicals, and pharmaceutical proteins. The long history of yeast in the development of 
diverse bioprocesses have led to the accumulation of a wealth of data about its 
physiology, biochemistry, and regulation (Walker, 1998). These studies have established 
yeast as a robust industrial organism (Petranovic & Vemuri, 2009) and with the current 
renaissance in pushing for the production of fuels and chemicals from renewable 
resources, the interest in yeast has exploded and we expect it will grow stronger. A 
deeper understanding of its cellular physiology and metabolism can help us to better 
engineer S. cerevisiae to improve the efficiency of production of heterologous products 
(Bro, et al., 2003, van Maris, et al., 2007, Wattanachaisaereekul, et al., 2007, Wisselink, 
et al., 2009, Zelle, et al., 2010).  
  
In addition, in the last 25 years, yeast has been used extensively as a model system for 
the study of cell cycle and its connection to cancer (Hartwell, 2004). The similarities of 
carbon, energy and lipid metabolism between yeast and humans have also made yeast an 
excellent model system of choice for the study of the role of metabolism in disease 
etiology and treatment (Petranovic & Nielsen, 2008, Nielsen, 2009, Bolotin-Fukuhara, et 
al., 2010). 
The emergence of functional genomics and systems biology has opened new 
perspectives for the analysis and the study of biological organisms, and yeast was one of 
the first organisms to be studied during the development of these technologies. Nielsen 
and colleagues have reviewed and discussed the development and uses of these 
technologies in yeast research and development (Jewett, et al., 2005, Nielsen & Jewett, 
2008). One of the key messages from these reviews is the importance of metabolic fluxes, 
as the final outcome of intricate interactions between the different networks; the networks 
of transcription, translation, post-translational modification, signal transduction and 
protein-protein interaction. 
Network analysis has been a major effort in the area of biological sciences (Albert & 
Barabasi, 2002, Newman, 2003, Barabasi & Oltvai, 2004, Papin, et al., 2004, Joyce & 
Palsson, 2006, Feist, et al., 2009). Technologies that emerged from the progress in 
genomics have allowed the experimental identification and verification of interactions 
between genes and their products, from proteins to metabolites to integrated phenotypes, 
and a wealth of computational methods has been developed, and is continuously 
developing, for the integration of this information into networks and their analysis. The 
ultimate goal of these methods is to synthesize the knowledge into predictive 
  
mathematical models that can be used in computational analyses to provide insight and 
accelerate discovery. 
Although it is acknowledged that it is difficult to classify mathematical models in 
systems biology, two main classes are mainly considered (Nielsen & Jewett, 2008): top-
down models, where new biological information is extracted from large-data sets and the 
analysis used there is mainly inductive (Kell, 2005, Joyce & Palsson, 2006, Ananiadou, et 
al., 2010), and bottom-up models, which are built on detailed mechanistic knowledge and 
the analysis is deductive but is limited to small networks (Rieger, et al., 2005). And 
herein lies the major challenge in systems biology, the ability to build models with the 
mechanistic quality of the bottom-up models and the scale (i.e., number of components 
and interactions) of the top-down models (Papin, et al., 2004, Mehra & Hatzimanikatis, 
2006).  
Nielsen and Jewett observed that although it is difficult to reconcile bottom-up and top-
down modeling, the efforts in curating and building metabolic network models has been 
close to achieving this (Nielsen & Jewett, 2008). The combined knowledge of 
physiology, biochemistry and metabolism allow the reconstruction of networks, which 
are further curated using flux balance analysis (FBA) to complete missing parts and 
derive a functional metabolic network. The continuing integration of knowledge about 
the networks that regulate the activity of the metabolic activities is the first successful 
demonstration of bridging the gaps between the functional regulatory networks (Papin, et 
al., 2004, Joyce & Palsson, 2006, Hyduke & Palsson, 2010, Schellenberger, et al., 2010, 
Hasunuma, et al., 2011). 
  
This remarkable progress in the area of metabolic modeling is very good news for those 
working in yeast metabolism, physiology, and bioprocessing. The systems-level, 
genome-scale understanding of carbon and energy metabolism is critical to enhance our 
metabolic toolbox for optimizing the production of industrial chemicals and fuels from 
yeast. Additionally, it can also help in the elucidation of the etiology of many metabolic 
diseases. Understanding carbon metabolism and energy management is also important for 
understanding and engineering stress tolerance, which is an unavoidable consequence 
from the bioprocess conditions (e.g., high titers and low pH) (Nicolaou, et al., 2010), and 
cellular stress has also been implicated in many diseases (Costa & Moradas-Ferreira, 
2001, Sorolla, et al., 2008). 
However, many important technological issues limit the full promise of useful 
applications of metabolic models in yeast. While we know very well the structure of the 
model, i.e., the biochemistry and many regulatory connections, we do not have enough 
global-scale data. Rather, we have partial data from proteomic, metabolomics, and 
physiology studies, and in many cases, uncritical analysis of partial data can lead to 
erroneous conclusions.  Another problem arises from the complexity of biological 
systems and the large-scale, high-throughput nature of the data, as there are also 
differences in results that arise from the “same” studies in different laboratories, an 
important issue that has been recently acknowledged and addressed in various studies 
(Lin, et al., 2009, Ukibe, et al., 2009, Hong, et al., 2010, Zhao, et al., 2010). 
In all the studies of networks in yeast, the information is mainly qualitative, i.e., 
network interactions are described as on/off properties, with very little information on the 
strength of these interactions. Hence, while these networks can be used to integrate and 
interpret quantitative observations, such as fluxes and expression data, they can only 
  
simulate and predict experiments that disrupt the network connectivity, such as gene 
knock-out, loss-of-function mutations, and mutations of gene regulatory elements. The 
ultimate objective would be to formulate models that can both describe the steady-state 
behavior and predict the dynamic responses of yeast metabolic networks in order to guide 
how the system would behave to knock-in or knock-out of genes. This would allow us to 
manipulate the metabolic network to achieve our desired objectives. We will discuss here 
some of the approaches towards this objective and how integration of thermodynamic and 
kinetic properties can bring us closer to that aim. 
 
SOME CONSIDERATIONS IN THE USE AND APPLICATIONS OF THE 
GENOME-SCALE METABOLIC MODEL OF YEAST 
Genome-scale metabolic models have gained significant popularity as versatile tools in 
many studies (Feist & Palsson, 2008, Oberhardt, et al., 2009) and they have proven to be 
valuable assets in guiding metabolic engineering decisions (Bro, et al., 2003, Patil, et al., 
2004). With the development of high-throughput and automated reconstruction methods 
(DeJongh, et al., 2007, Henry, et al., 2010, Radrich, et al., 2010), genome-scale 
metabolic reconstructions have been increasing with an accelerated pace, even though 
their number still lags behind that of number of genome sequences being completed. 
The first genome-scale metabolic model of the yeast Saccharomyces cerevisiae, named 
iFF708, was published in 2003 (Famili, et al., 2003, Forster, et al., 2003). This model 
was subsequently modified through the inclusion of additional biochemical reactions, 
genes, regulatory constraints and compartments (Duarte, et al., 2004, Kuepfer, et al., 
2005, Herrgard, et al., 2008, Nookaew, et al., 2008). Three laboratories, two of which 
have collaborated in the development of the original model, have led the main 
  
developments of these models. Recently, a “consensus” model has been developed 
through a collaborative approach of a community of yeast researchers to serve as a 
resource for collecting and summarizing the current and growing knowledge of yeast 
metabolism (Herrgard, et al., 2008). 
A main use of the genome-scale models is the study of the physiology of gene 
deletions. Snitkin et. al. (Snitkin, et al., 2008) compared model (iFF708) predictions 
against 465 gene deletion mutants under 16 conditions and found a high fraction of 
correct predictions (94%) that validated the high predictive capacity of the model and 
demonstrated how inconsistencies can also be used to drive further hypothesis testing. 
What is interesting in this study is that, Segre and colleagues used the disagreements 
between model predictions and experiments to guide experimental refinement, which also 
improved significantly the experimental data. After these refinements in experimental 
information, they repeated the computational analysis and comparisons with experiments 
to improve and refine the genome-scale metabolic model. 
 The first yeast genome-scale model has until now (September 2011), 365 citations, 
with 79 reviews and 263 research articles, suggesting an important impact in yeast 
research. However, a few observations can be made regarding the applications of the 
model. First, a very small number have used the model for discovery of genetic 
modifications and guidance for metabolic engineering towards the improved strain 
performance. In the first of the three most notable cases, the model was used to identify 
and rank a set of gene deletions and insertions for the manipulation of redox metabolism 
towards increased of ethanol yield (Bro, et al., 2006). Experimental implementation 
validated the predictions and demonstrated improved ethanol yields even on 
xylose/glucose mixtures. The second notable case involves the identification of five, 
  
nonobvious gene deletions for the engineering of C1 metabolism (Kennedy, et al., 2009). 
Finally, in the third case, the yeast genome-scale model was used for the identification of 
metabolic engineering targets for improving the production of sesquiterpenes 
(Asadollahi, et al., 2009). The complexity of the pathway and its distance from the 
central carbon pathway (there are 8 reactions in the mevalonate pathway from acetyl-
CoA to farnesyl-diphosphate which is the primary precursor of the various 
sesquiterpenes) made the use of the genome-scale model indispensible. The resulting 
metabolic engineering strategy, which involved multiple genetic modifications, 
demonstrated the value and the validity of the model. 
On the other hand, a large number of papers that cited the first yeast genome-scale 
model, focused on metabolomics analysis. However, they primarily use the model as a 
high-quality curated database of metabolites and reactions. While this two-dimensional 
annotation has been one of the objectives in genome-scale modeling (Palsson, 2004, 
Reed, et al., 2006), it does not contribute immediately into design of strategies for strain 
improvement of disease treatment.  
The work by Patil and Nielsen (Patil & Nielsen, 2005) has been an enabling 
breakthrough because it allowed the integration of gene expression and metabolomic data 
into the genome-scale metabolic model for the identification of network patterns that 
follow a common transcriptional response. The algorithm they developed identifies 
reporter metabolites and a set of connected genes with significant coordinated changes to 
genetic and environmental perturbations. This method allows now to use the genome-
scale model, together with other genomic technologies, such as transcription factor 
enrichment, for the identification of important regulatory proteins and their associated 
  
regulatory networks (Cakir, et al., 2006, Raghevendran, et al., 2006, Fazio, et al., 2008, 
Cimini, et al., 2009). 
Finally, the integration of proteomics information within the context of genome-scale 
modeling is a recent exciting development (Costenoble, et al., 2011). While this study 
focused in the study of metabolic adaptation to changes in nutritional conditions, it 
demonstrated the feasibility to use targeted proteomics for the quantification of almost all 
the enzymes in central carbon and amino-acid pathways. The synergistic application of 
these technologies and methodologies with genome-scale model analysis will be a major 
progress for metabolic engineering. 
 
APPROACHES TO ADDRESS SOME ISSUES IN THE FLUX BALANCE 
ANALYSIS OF METABOLIC MODELS 
The discussion above highlights a surprisingly limited use of genome scale models for 
metabolic engineering. It appears that the community working in this field has been more 
active with generating new and larger models and less so with actually using the models. 
As Uwe Sauer observed (personal communication), it is the latter that matters, but in 
every nascent field it is a bit like that because it is easier to develop tools than to reach 
new scientific discoveries by applying them, and metabolomics or fluxomics are no 
different in this respect. 
The limited uses of genome scale models are due to many challenges and issues, which 
make it hard for somebody without a good experience in modeling and computation to 
use them in a productive fashion. One of the key challenges in FBA of genome-scale 
models is the possibility of multiple solutions resulting from the underdetermined nature 
of the problem. The number of alternate solutions scale exponentially with the size of the 
  
network (Mahadevan & Schilling, 2003). Even though there are methods that aim to 
characterize the different flux modes in order to systematically analyze the possibilities, 
such as Elementary Flux Modes (EFM), Extreme Pathway (EPs) and other variants, most 
of these methods still do not perform well as the size of the model increases, and their 
applicability and usefulness are restricted. Therefore, given the limited amount of 
information about certain fluxes or enzyme activities, the main challenge is how we can 
derive a representative or characteristic flux distribution that can explain the observed 
phenotype at steady state. Such representative flux state(s) could also be a combination of 
more elementary flux states that should be further identified and characterized 
(Hoffmann, et al., 2006, Barrett, et al., 2009, Llaneras & Pico, 2010). 
Flux balance models of metabolism are routinely used in the fitting of labeling 
experiments for the quantification of metabolic fluxes. However, all of these studies, with 
one notable exception (Blank, et al., 2005), employ small scale, reduced models of yeast 
metabolism and they derive additional constraints for determining unique flux profiles. 
The concept of core models is not new; in fact historically genome-scale models have 
evolved from reduced “core” stoichiometric models by including increasingly details. 
The scale of these models made them more manageable and facilitated analysis. The 
issue of manageability is illustrated by the number of possible flux modes that the 
network can have, e.g. for a small yeast network comprising 53 reactions, there can be up 
to 6,741 EFMs depending on the carbon source (Dunn, et al., 1994) whereas for an E. 
coli model with 112 reactions, the number of EFMs calculated was 2,450,787 (Perko, 
1986). Hence, even though there are methods that can allow the almost complete 
enumeration and characterization of the EFMs/EPs, the scale of the resulting number of 
  
possibilities will remain a huge obstacle in analysis and we must make some drastic 
assumptions to reduce the possibilities.  
Another driver in the use of reduced models has been the objective to understand 
central metabolism well enough, before attempting to understand and make predictions at 
the genome-scale. Actually, in most of the problems in metabolic engineering the desired 
outcome has been the manipulation of central metabolism for redirecting the carbon flux 
towards desired pathways. 
However, reduced models that are used to perform analyses of experimental data are 
often incompatible with each other as the set of reactions, components and degree of 
detail (e.g. proton-balancing and balancing of cofactors, etc.) differ significantly. 
Moreover, there is not an explicit list of the assumptions that would allow consistency 
checks of the model. For example, the assumptions about the presence or absence of 
alternate pathways in the determination of flux ratios for labeling experiments will affect 
the variability of the flux distribution. This can lead to different conclusions arising from 
the same set of data and difficulty in cross-utilization of datasets across laboratories that 
could have helped to further the complete characterization of the network.  
Typically, reduced or core models in the past have been built in a bottom up approach. 
We believe that we need a top-down approach that can take advantage of all the 
knowledge in the genome-scale models. One of the main objectives of such approach will 
be to recover the simplicity and clarity of these earlier core models without losing the 
annotation details and the curated knowledge that has been amassed into the genome-
scale models. With the increasing addition of details in these genome-scale models, it is 
necessary and important to add new knowledge consistently and modularly in order to 
keep track of changes, for example, with different releases of the S. cerevisiae 
  
reconstructions. Moreover, a computational method will allow for a systematic and 
unambiguous model reduction, and it will facilitate consistency and communication 
between different laboratories. 
Thermodynamic analysis of metabolic networks has been also shown to be important in 
reducing the flux space and eliminating thermodynamically infeasible pathways (Henry, 
et al., 2007, Boghigian, et al., 2010, Soh & Hatzimanikatis, 2010). Thermodynamics can 
also help to eliminate the need for ad hoc assignment of reaction directionality that can 
unwittingly preclude possible flux distributions that might be of interest. An example is 
the phosphoenoylpyruvate carboxykinase (PEPCK) reaction that is often assumed to be 
operating in the ATP-utilization direction. However, as shown both experimentally and 
computationally, this reaction can operate in the reverse direction under certain 
conditions (Deok, et al., 2006, Gorsich, et al., 2006, Singh, et al., 2011). Hence by 
assuming certain fixed directionalities in the model, we might eliminate prematurely the 
true state of the network prior to analysis. Therefore, thermodynamics must be used to 
improve the curation of the models, as they provide additional control over the decision 
between the assumed, in literature or based on generalized arguments, reaction 
directionality vs. the possible reaction directionality, based on the estimated Gibbs free 
energy and the possible range of metabolite concentrations in the cell or metabolomics 
data. 
Besides reducing the flux space effectively, thermodynamics offer another approach for 
integrating and overlaying additional layers of information in the form of thermodynamic 
displacement and metabolite concentration information. It has been shown (Henry, et al., 
2007, Soh & Hatzimanikatis, 2010) that if we include additional information in the form 
of metabolomics and fluxomics data, we can reduce the possible flux ranges of the 
  
network to help us in better characterization of the flux distribution. Network 
thermodynamics can also be used to check for consistency of the metabolomics data with 
flux data, since we would expect that the directionality of the reactions, as determined by 
the full set of metabolites measured in an experiment, is not in conflict with the 
directionality of the reactions as determined from the labeling data. 
As FBA models are only snapshots of the network at a point in time and they do not 
allow us to extrapolate the dynamic response of the network. Although approaches based 
on FBA (Mahadevan, et al., 2002) attempt to overcome this limitation, these methods 
often use a highly reduced model, and they cannot simulate or predict the response of the 
metabolite levels since they do not integrate kinetic information. The biggest limitation of 
FBA methods is their inability to predict response to changes in enzyme activities. In 
most case in metabolic engineering we are interested to identify enzymes as targets for 
overexpression and/or downregulation, since gene knock out can have a detrimental 
effect on the physiology of the strain. A recent, very interesting study investigated the 
effects of single nucleotide polymorphisms (SNPs) on the phenotypic differences 
between two different yeast strains (Canelas, et al., 2010). The investigators found SNPs 
in 20% of the metabolic genes and based on these differences they hypothesized 
physiological differences, which they confirmed experimentally. Based on further 
transcriptomic analysis, the authors hypothesized that SNPs can be responsible for 
change in enzyme concentration and/or function, such as kinetic properties. Such 
hypotheses, as well as identification of targets for gene overexpression and protein 
engineering, cannot be analyzed without the use of kinetic models of metabolic networks. 
 
  
SOME CONSIDERATIONS ON THE DEVELOPMENT OF KINETIC MODELS 
OF YEAST METABOLISM 
One of the more widely used yeast kinetic models (Teusink, et al., 2000) for analysis 
and also further model development has about 257 citations to date (September 2011). 
However, very little has been done in the original development of large-scale kinetic 
models in yeast. With the exception of one case (Wang & Hatzimanikatis, 2006), almost 
all models of yeast central carbon catabolism do not distinguish the mitochondrial 
reactions from the cytosolic reactions. The main issue in the development of kinetic 
models of metabolic networks is the limited available information and the uncertainty 
associated with this information. We have previously studied and classified the 
uncertainty in the study of metabolic pathways in two types: structural and quantitative 
(Miskovic & Hatzimanikatis, 2010). Structural uncertainty concerns the limited 
knowledge in the stoichiometry and in the kinetic laws of the enzymes in the pathways. 
While the stoichiometry of the pathways in yeast is well characterized, there still exist 
gaps in some pathways and the kinetics of their enzymes are completely unknown 
(DeJongh, et al., 2007, Feist, et al., 2009, Henry, et al., 2009, Kumar & Maranas, 2009, 
Stanley, et al., 2010). Also the kinetic parameters of most of enzymes are not available 
and when they are available they are usually known as “apparent Km’s” but not as 
parameters in detailed kinetic mechanisms. There is also an important concern on how 
the parameters of the enzymes quantified in vitro will change in the crowded intracellular 
environment (Savageau, 1995, Schnell & Turner, 2004).  
Flux distributions, thermodynamic information, metabolite concentration and kinetic 
parameters are subject to quantitative uncertainty. Despite the advances of methods for 
the quantification of metabolic fluxes, they still carry some error. The thermodynamic 
  
properties of most of the reactions are estimated using group contribution methods, and 
therefore they contain estimation errors and the error of the experiments used in the 
estimation process (Jankowski, et al., 2008). The highest uncertainty is in the metabolite 
measurements, and in addition only a relatively small number of metabolites can be 
measured compared to the entire metabolome of the organism. 
The uncertainty in building mathematical models is very large even for systems that are 
well studied, such as E. coli and S. cerevisiae. Therefore, when we consider the analysis 
and engineering of novel pathways, we should expect much higher qualitative and 
quantitative uncertainty in the information about these systems (Tyo, et al., 2007, Alper 
& Stephanopoulos, 2009). 
Uncertainty is a problem common in many areas of physical and chemical sciences and 
engineering. Within these fields there exist a large number of methods and approaches 
that allow for the modeling and quantification of uncertainty. These methods have been 
used in the analysis of metabolic networks and they have provided some insight into the 
properties of the networks, and guidance for metabolic engineering (Wang, et al., 2004, 
Wang & Hatzimanikatis, 2006, Wang & Hatzimanikatis, 2006, Kiparissides, et al., 2009). 
However, any significant effort in this area faces challenges in the modeling and 
simulation of uncertainty. When we consider uncertainty modeling and analysis of kinetic 
models of chemical and biochemical systems, we must ensure sufficiency in the sampling 
of the kinetic parameters, calculate the properties of a population of the system, solve 
large systems of nonlinear equations, and perform a statistical analysis to characterize the 
properties of the population of the system. This leads to many computational challenges: 
(i) the ranges of the parameter values are not known or they are very large; (ii) the size 
and nonlinearities introduce computational difficulties; and (iii) reliable statistics can 
  
require a computationally prohibiting number of samples. We have recently developed an 
uncertainty analysis framework, tailored to metabolic systems, and we have made 
significant progress in addressing these issues (Miskovic & Hatzimanikatis, 2010). 
 
PREDICTING NETWORK RESPONSES WITH LIMITED INFORMATION 
Optimization and Risk Analysis of Complex Living Entities (ORACLE) is a modeling 
and computational framework we have recently introduced for the study of metabolic 
networks under uncertainty (Wang, et al., 2004, Wang & Hatzimanikatis, 2006, Wang & 
Hatzimanikatis, 2006, Miskovic & Hatzimanikatis, 2010). It uses uncertainty and risk 
analysis methods, and it circumvents most of the limitations mentioned above. In its 
current stage ORACLE is used for Metabolic Control Analysis (MCA) and it allows the 
quantification of the flux control coefficients and concentration control coefficients. 
These coefficients quantify the fold-change in metabolic fluxes and metabolite 
concentrations for a fold change in enzyme activities or in any environmental parameter. 
There are other similar algorithms for analysis of kinetic metabolic models (Steuer, et al., 
2006, Tran, et al., 2008) and a recent paper (Miskovic & Hatzimanikatis, 2011) explains 
the differences between ORACLE and these approaches. Main advantages of the 
ORACLE framework are: (i) the capability to consistently integrate thermodynamics and 
physico-chemical constraints into kinetic models, (ii) the capability to integrate omics 
information (transcriptomics, proteomics, metabolomics, and fluxomics) and (iii) its 
scalability that enables to predict kinetic responses of metabolism even for genome-scale 
metabolic models, which is not feasible with any of the other approaches. 
  
The pivotal point in the development of ORACLE is the recognition that control 
coefficients depend on the degree of enzyme saturation, also known as enzyme 
elasticities, which in turn can be estimated through the distribution of the enzyme 
between the different mechanistic enzyme states. This observation led us to the 
reconsideration of the uncertainties in the enzyme state space instead of the kinetic 
parameter space. This reformulation gives the major advantage that we can derive the 
degree of saturation, or elasticities, by sampling the enzyme state space, which, unlike the 
parameter space, is very well bounded between 0 and 1. These bounds can be further 
constrained if the kinetic parameters of an enzyme are approximately known. 
The ORACLE framework involves a set of computational procedures, which integrate 
the available information into a mathematical structure, and through Monte Carlo 
sampling for retrofitting missing information they generate the population of all possible 
control coefficients. Conceptually, ORACLE involves the following steps (Figure 1): 
 
Step 1. Integration of available information. We start by defining the stoichiometry, 
based on the information from the genome scale model. We proceed further by 
integrating the estimated flux profiles based on information from fluxomics analysis 
or on hypotheses about desirable flux distributions in an engineered pathway. Finally, 
we estimate the standard free energy of reactions based on the available experimental 
information, or using group contribution methods. 
  
Step 2. Exploring the space of metabolite concentrations. The levels of concentrations 
for some of the metabolites in the system might be available, or can be estimated 
from experiments under similar physiological conditions. For the metabolites whose 
levels are missing, we can use sampling under thermodynamic constraints in order to 
preserve the observed flux directionality. 
Step 3. Exploring the space of the kinetic properties (elasticities). Sampling of either 
the enzyme states (Miskovic & Hatzimanikatis, 2011) or the degree of saturation of 
the enzymes active site (Wang, et al., 2004) is very efficient and it can also integrate 
partial knowledge of the enzyme kinetic parameters. 
Step 4. Consistency checks and pruning. Partial knowledge of experimentally observed 
response of a metabolic flux to the changes in the activity of an enzyme is used to 
reject inconsistent samples. 
Step 5. Calculation and statistical analysis, data mining, and visualization of control 
coefficients.  The populations of control coefficients are subsequently analyzed using 
non-parametric statistics and data mining in order to asses and rank the importance of 
the enzymes with respect to their impact on the specified objectives (Silverman, 1986, 
Conover, 1998, Chen & Lonardi, 2009). 
Ultimately, the results from ORACLE are not predictions but statistical expectations of 
success of the metabolic engineering targets they identify. ORACLE provides a set of 
alternative solutions, evaluated with respect to their uncertainty, which can be given back 
to the experts for evaluation. This ‘expert opinion’ is the ultimate integration of 
information that is almost impossible to take into account during the formulation of the 
model. Overall, ORACLE employs modeling and analysis in a new way, which have 
been successfully used in other disciplines. 
  
 
THERMODYNAMIC AND KINETIC ANALYSIS OF A REDUCED, CORE 
METABOLIC MODEL OF YEAST 
In this section, we will discuss some of our recent unpublished work to illustrate how we 
can approach some of the problems discussed earlier in the paper. Our work is based on a 
core yeast metabolic model. We have developed a computational algorithm that allows 
the reduction of genome scale models into core metabolic models. This method allows 
the unambiguous reduction of genome scale models and it is also “reversible”, in the 
sense that the results from the analysis of the core model can be compared exactly with 
the genome scale model. The reduction was based on the iMM904 model (Mo, et al., 
2009) and this is the first such core model for yeast and it consists of 89 reactions and 88 
metabolites across 2 compartments (cytosol and mitochondrial) as shown in Figure 2. All 
the reactions are proton-balanced as it has been shown to be important in affecting the 
overall solution (Fox, et al., 2007). Modeling the reactions around, across, and inside 
compartments is very important for understanding the in vivo redox and energy balance 
(Karbowicz & Smith, 1984), but unfortunately is often neglected in most reduced models. 
In addition, we performed thermodynamic curation and we have been able to include 
thermodynamic constraints in our reduced model. 
We first used this model to perform some basic flux balance analysis, and we used 
reference experimental data from recent work from the Sauer Lab to compare our results. 
Initially we used only information about the carbon source uptake rate and product fluxes 
(Wang, et al., 2011) and without assuming any reaction directionalities a priori, we 
performed FBA and flux variability analysis without any thermodynamic constraints. As 
expected, we found that the system is under-constrained and it is able to generate biomass 
  
from CO2 recycling reactions and ATP recycling. However, after adding thermodynamic 
constraints, we observe that the maximum biomass flux drops to close to the measured 
value as many of the CO2 recycling reactions are automatically constrained in the proper 
direction under normal physiological concentration ranges predicted by the 
thermodynamic constraints (Figure 3). On the other hand, when we fix the reaction 
directionalities in the direction most commonly assumed in genome scale models, we 
find that the flux variability is significantly reduced (Figure 4). By specifying the reaction 
directionality a priori, we can overly constraint the model in two ways. First, as 
discussed earlier, reactions that can be reversible under certain conditions, e.g. in the case 
of PEPCK which was found to be able to operate in the ATP-generating direction in E. 
coli (Deok, et al., 2006, Singh, et al., 2011) and in S. cerevisiae (Gorsich, et al., 2006) 
under high CO2 concentrations. Hence by setting the reaction directionality a priori we 
would have eliminated this possibility and we could not explain the observed physiology 
using the model. Second, by assigning a priori directionalities, we introduce in the 
system ad hoc inflexibility and tight constraints, as we observe that, even with 
thermodynamic constraints, the flux ranges are quite large as compared to those with 
specified reaction directionalities. Although in metabolomics and fluxomics studies, we 
would like the model to have few degrees of freedom, in order to have smaller 
uncertainties in the estimation of the flux values, we should not contaminate our analysis 
with artifacts from arbitrary assumptions about reaction directionality. 
All these results and conclusions from FBA of the core model have been found to hold 
when we used the corresponding genome scale model used to derive the core model. 
Therefore, researchers who are familiar with FBA on small stoichiometric models, but 
they are not experienced working with genome scale models, can use and analyze this 
  
reduced core model much easier, and their results and conclusions can then be used for 
genome-scale analysis.  
After obtaining a representative flux profile from the thermodynamics-based flux 
balance analysis (TFBA), we sampled feasible metabolite concentrations and computed 
the corresponding reaction displacement from thermodynamic equilibrium. We observed 
(Figure 2) that the displacement of approximately half of the reactions could be either 
near or far from equilibrium, whereas the other reactions could assume a wider range of 
displacements (Table 1). 
We also used ORACLE to investigate how changes in the activities of the enzymes in 
the network would affect the flux distribution and the levels of the metabolites. We 
investigated the response of the splitting ratio of the glycolytic fluxes, quantified by the 
ratio of the flux through fructose-biphosphate aldolase (FBA), over the flux through 
glucose-6-phosphate-1-dehydrogenase (ZWF). We found that the primary positive 
control over this ratio lies in ATP maintenance and pyruvate decarboxylase (PDC), 
whereas the negative control lies in ammonia (NH4t) and oxaloacetate (OAt) transport 
(Figure 5). Interestingly, even though an enhancement of hexose transporters (HXT) or 
hexokinase (HXK) activity has, in average, negative impact on this ratio error bars 
suggest that there exist physiological states where its effect could be positive. 
The ATP/ADP ratio and the redox potential (NADH/NAD) are important factors in 
metabolic engineering as adenylate cofactors and pyridine nucleotides are involved in 
many reactions. Our analysis suggests that the control over these quantities is distributed 
differently depending on the compartment of the cell. More specifically, we observe that 
a group of enzymes, i.e. HXT, PDC, external NADH dehydrogenase (NDH), ATP 
synthase (ASN) and CO2 transport, have positive control, and ATPM, ADP/ATP carrier 
  
protein (AAC) have negative control over ATP/ADP ratio in the mitochondria, (Figure 
6A). On the other hand, in the cytosol the positive control over ATP/ADP ratio is 
primarily from HXT, whereas the negative control is shifted to PDC, pyruvate 
dehydrogenase (PDA) and NH4t (Figure 6B). Similarly, we observe that the major 
positive control over redox potential in mitochondria (Figure 6C) is in glucose-6-
phosphate isomerase (PGI), and the negative control is distributed between ZWF, CO2 
and 6-Phospho-D-glucono-1,5-lactone lactonohydrolase (GND1). In contrast, in the 
cytosol the biggest positive control coefficients of energy charge are those with respect to 
PGI nad ATPM, whereas HXT and HXK appear to have the most important negative 
control. This interesting connection of the redox potential in the mitochondria and the 
activities in the upper glycolysis and pentose phosphate can be identified and explained 
only through the application and use of ORACLE. 
We also have analyzed how the control is distributed over the ethanol yield (with ethanol 
being as one of most important industrial products) from glucose. Though ATPM and 
HXT have major positive and negative effect respectively (Figure 7), we observe that the 
control coefficients are very small in magnitude, and even for the most significant 
enzymes the mean value is not bigger than 0.1 suggesting that activities of multiple 
enzymes should be altered to effectively increase ethanol yield. 
Table 1: Distribution of reactions’ displacement from thermodynamic equilibrium 
in the network 
 NE (I) Between (II) FA(III) I+II II+III I+II+III 
Number of rxns 9 0 27 11 6 22 




The integration of regulatory constraints will be the next major advancement in the area 
of metabolic modeling in yeast. Past and ongoing work in the Palsson and Nielsen labs is 
advancing rapidly developments in this area. An interesting approach could come from 
the combination of concepts from the work of Patil and Nielsen (Patil & Nielsen, 2005) 
and the work by Price (Hasunuma, et al., 2011). Such approach will provide important 
missing links for the development of kinetic models. 
Ultimately a kinetic, nonlinear model is the goal. While there exist a number of 
publications, which claim such models, they all face a lot of limitations, which has not 
been adequately addressed. We should always keep in mind the proverbial quote from 
Manfred Eigen: “A theory has only the alternative of being right or wrong. A model has a 
third possibility: it may be right, but irrelevant.” The relevance of the mathematical 
models in yeast will be evaluated from their contribution to the advancement in our 
understanding of disease and to the accelerated development of industrial strains. While 
there is a lot of evidence from the research fronts in these areas, successful resolution of 
some of the issues discussed in this article will enhance and broaden the impact of 
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Figure 1. Flowchart of computational procedures for uncertainty analysis of metabolic 
networks within the ORACLE framework. Available information from different sources 
is integrated in the model through the successive application of the ORACLE procedures. 
The resulting models are consistent with the thermodynamics and experimentally 
observed data, while preserving all physical and chemical constraints of the underlying 
metabolic network.  
Figure 2. Core metabolic network of S. cerevisiae showing the thermodynamic 
displacement of reactions in the network. The abbreviations for the pathway steps and 
enzymes can be found in the Appendix. 
Figure 3. Effect of thermodynamic constraints on biomass flux 
Figure 4. Flux Variability Analysis of central metabolic network of S. cerevisiae without 
and with thermodynamic constraints 
Figure 5. Distribution of the control coefficients of the splitting ratio between the fluxes 
through fructose-biphosphate aldolase (FBA) and glucose-6-phosphate-1-dehydrogenase 
(ZWF) with respect to enzymes having the most of control over this ratio. The bars 
represent the mean values of the control coefficients, while the errorbars correspond to 
the 25 and 75 percentiles of the control coefficients with respect to their mean values. 
The abbreviations for the enzymes are given in Fig. 1. 
Figure 6. Distribution of the control coefficients of: (A) ATP/ADP ratio in mitochondria 
(ATPm/ADPm), (B) ATP/ADP ratio in cytosol (ATPc/ADPc), (C) redox potential in 
mitochondria (NADHm/NADm) and (D) redox potential in cytosol (NADHc/NADc), with 
respect to enzymes having the most of control over these quantities. 
Figure 7. Distribution of the control coefficients of ethanol yield from glucose with 






Names of metabolites and reactions of network in Figure 2: 
HXT, hexose transporters for glucose; HXK, hexokinase; PGI, glucose-6-phosphate 
isomerase; PFK, phosphofructokinase; FBA, fructose-biphosphate aldolase; TPI, 
triose phosphate isomerase; TDH, glyceraldehyde-3-phosphate dehydrogenase; PGK, 
phosphoglycerate kinase; GPM, phosphoglycerate mutase; ENO, enolase; PYK, 
pyruvate kinase; ZWF, glucose-6-phosphate-1-dehydrogenase; RKI, ribose-5-
phosphate isomerase; RPE, ribulose-5-phosphate 3-epimerase; TKL1, transketolase; 
TKL2, transketolase; TAL, transaldolase; PDC, pyruvate decarboxylase; ALD, 
aldehyde dehydrogenase; ACS, Acetyl-CoA synthase; CAT, carnitine o-
acetyltransferase; ACARtrans, acetylcarnitine diffusion; YAT, carnitine o-
acetyltransferase; CARtrans, carnitine diffusion; PYRtrans, pyruvate carrier; PDA, 
pyruvate dehydrogenase; PYC, pyruvate carboxylase; PCK, phosphoenolpyruvate 
carboxylkinase; OAtrans, oxaloacetate carrier; MAE, malic enzyme; CIT, citrate 
synthase; ACO, aconitase; IDH, isocitrate dehydrogenase; KGD, a-ketoglutarate 
dehydrogenase; LSC, succinate-CoA ligase; SDH, succinate dehydrogenase; FUM, 
fumaratase; MDH, malate dehydrogenase; NDH, external NADH dehydrogenase; NDI, 
NADH dehydrogenase; NDR, NADPH reductase; QCR, ubiquinol cytochrome C 
reductase; COX, cytochrome C oxidase; ASN, ATP synthase; AAC, ADP/ATP carrier 
protein; ADK, adenylates kinase; ATPmt, ATP maintenance; ADH, cytosolic alcohol 
dehydrogenase; SCD, succinate dehydrogenase (ubiquinone-6), mitochondrial; ACET, 
acetate diffusion; COH, carbonic acid hydro-lyase; PPP, Pyrophosphate 
phosphohydrolase; MLPIT, malate transport, mitochondrial; ICL, Isocitrate 
  
glyoxylate-lyase; MLS, L-Malate glyoxylate-lyase (CoA-acetylating); MDHc, (S)-
malate:NAD+ oxidoreductase; CITc, Citrate oxaloacetate-lyase  cytosolic; ACOc, 
citrate hydro-lyase cytosolic; LACm2r, D-lactate transport, mitochondrial; CITt2m, 
citrate transport, mitochondrial; LDH, (R)-Lactate:ferricytochrome-c 2-
oxidoreductase; O2m, O2 transport (diffusion); CO2m, CO2 transport (diffusion), 
mitochondrial; PIm, phosphate transporter, mitochondrial; CO2t, CO2 transport via 
diffusion; GLYCt, glycerol transport in/out via diffusion reversible; PYRst, Pyruvate 
transport via proton symport; SO4t, sulfate transport via proton symport; Pit, 
phosphate transport via proton symport; O2t, O2 transport via diffusion; NH4t, 
Ammonia transport via diffusion; LACt2r, D-lactate transport via proton symport; 
SUCCt2r, succinate transporter in/out via proton symport; MALt2r, L-malate 
transport in via proton symport; GND1, 6-Phospho-D-glucono-1,5-lactone 
lactonohydrolase; GND2, 6-Phospho-D-gluconate:NADP+ 2-oxidoreductase 
(decarboxylating); GPD1, Glycerol-3-phosphate:NAD+ 2-oxidoreductase; GPD2, 
Glycerol-3-phosphate phosphohydrolase. The abbreviations for the chemical 
species: XL, xylose; XLT, xylitol; XYLL, xylulose; GLC, glucose; G6P, glucose-6-
phosphate; F6P, fructose-6-phosphate; FBP, fructose 1,6-diphosphate; T3P, 
glyceraldehydes-3-phosphate; DHAP, glycerone phosphate; DPG, 
bisphosphoglycerate; 3PG, 3-phosphoglycerate; 2PG, 2-phosphoglycerate; PEP, 
phosphoenolpyruvate; PYR, pyruvate; 6PGL, glucono-1,5-lactone 6-phosphate; RL5P, 
ribulose 5-phosphate; R5P, ribose 5-phosphate; X5P, xylose-5-phosphate; E4P, 
erythrose 4-phosphate; S7P, sedoheptulose 7-phosphate; AALD, acetaldehyde; ACET, 
acetate; ACCOA, acetyl-CoA; CAR, carnitine; ACAR, acetylcarnitine; OAA, 
  
oxaloacetate; CIT, citrate; ICIT, isocitrate; AKG, 2-oxoglutarate; SUCCOA, succinyl-
CoA; SUCC, succinate; FUM, fumarate; MAL, malate; GL, glycerol; ETH, ethanol; CO2; 
HCO3-; O2; PPi, Pyrophosphate; Pi, Phosphate; NH4; SO4; 6PGC, 6-Phospho-D-
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